Healthcare costs associated with short-acting β2-agonists in asthma: observational UK SABINA study

Background: Poor asthma control is associated with high short-acting β2-agonist (SABA) use. Aim: To assess asthma-related healthcare resource utilisation (HCRU) and medication costs associated with high versus low SABA prescriptions in the UK. Design & setting: Analysis of SABINA I (SABA use IN Asth...

Full description

Bibliographic Details

Main Authors:	Darush Attar-Zadeh, Toby Capstick, Deborah Leese, Sofie Arnetorp, Eleni Rapsomaniki, Keith Peres Da Costa, Ekaterina Maslova, Yang Xu, Danny Gibson, Jennifer K Quint
Format:	Artigo
Language:	Inglês
Published:	Royal College of General Practitioners 2023-09-01
Series:	BJGP Open
Subjects:	adrenergic beta-2 receptor agonist asthma emergency treatment health care costs prescriptions primary health care united kingdom
Online Access:	https://bjgpopen.org/content/7/3/BJGPO.2023.0015
Tags:	Add Tag No Tags, Be the first to tag this record!